openPR Logo

Press Releases from P&S Market Research - Pharmaceuticals (132 total)

Psoriasis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Paten …

The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of

Diabetic Foot Ulcer Therapeutics Pipeline Projects Immense Growth Ahead

The study analysed that the diabetic foot ulcer pipeline comprises of approximately 27 drug candidates in different stages of development. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/diabetic-foot-ulcers-therapeutics-pipeline-analysis Diabetic foot ulcer is a serious complication of diabetes and can be defined as the ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients. Diabetic foot ulcer is categorized into two types namely; neuropathic foot where

Technological Advancements at Cellular and Molecular Level Strengthening the IgA …

The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017

The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market As per the findings of research, it

Arthritis Therapeutics Pipeline Analysis, Clinical Trials & Results, Patent and …

Arthritis is an inflammatory disorder that occurs in joints and surrounding tissues. There are six types of arthritis namely osteoarthritis, autoimmune arthritis, psoriatic arthritis, juvenile arthritis, gout arthritis, and infectious arthritis. Symptoms of arthritis can include pain, swelling, redness, stiffness and decrease in movement. Some of the risk factors associated with arthritis are aging, obesity, joint injury, and family history. Certain laboratory tests such as blood test, and urine test,

Ascites Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Develo …

Ascites is one of the complications of liver diseases and is characterised by collection of fluid in the abdomen that causes swelling. More than 25 ml of fluid may accumulate in the peritoneal cavity. The disease can be caused by portal hypertension and low level of albumin protein in the blood. Hepatitis C or B infection, abdominal cancer, pancreatitis, congestive heart failure, portal vein thrombosis, and chronic alcohol abuse are

Acute Leukemia Therapeutics Pipeline Analysis

Acute leukemia is also known as cancer of blood cells in which immature blood cells modify into cancer cells. The disease arises from bone marrow and causes formation of numerous large blood cells. Leukemia is categorized into five different types namely acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, and hairy cell leukemia. Leukemia can produce be symptoms such as fever, recurrent nosebleeds, bone pain, swollen

Aneurysm Therapeutics Pipeline 2018 - Clinical Trials, Designation and Other Dev …

Aneurysm is a type of disorder that causes bulge formation in arteries. The disease generally occurs due to damaging of arteries. The bulge formation leads an increased force against an injured wall inside the artery. This further leads to rupturing of the artery and severe bleeding. Aneurysm mostly occurs in aorta that supply oxygen-rich blood from the heart to other parts of the body. There are certain risk factors associated

Angiosarcoma Therapeutics - Pipeline Review of the Top Drugs Companies 2018

Angiosarcoma is a type of soft-tissue sarcoma that arises from the endothelial cells. The disease is generally aggressive and characterized by extensively infiltrating anaplastic and rapidly proliferating cells. Angiosarcoma can occur in any part of the body but it is mostly found in the skin and soft tissues. Head and neck angiosarcoma accounts for around 50% of the cases of angiosarcoma. Cutaneous angiosarcoma is a type of angiosarcoma which is

Anorexia Therapeutics Pipeline 2018 -Clinical Trials, Patent, Designation and Co …

Anorexia is a type of eating disorder that is characterized by distortion of body image, intense fear of gaining weight, and extremely disturbed eating behaviour. Symptoms of anorexia can include low body weight, lack of menstruation among girls and women, severe food restriction, low blood pressure, brain damage, severe constipation, multi-organ failure and infertility. According to researchers, the risk factors associated with anorexia can be psychological, social, biological, behavioural, and

Valvular Heart Disease Therapeutics Pipeline Analysis 2018

Valvular heart disease is a condition in which heart valves does not work properly. There are four types of the valves present in the heart namely; tricuspid, mitral, pulmonary and aortic valves. Heart valves comprise of tissue flaps that open and close with each heartbeat and ensure the right direction of blood flow. Due to infections, birth defects, and age-related changes, heart valves do not function properly, with some of

Polycystic Ovary Syndrome Therapeutic Pipeline - Clinical Trials, Patent and Col …

Polycystic ovary syndrome refers to an imbalance of hormone that causes mood disorders, metabolic syndrome, insulin resistance and obstructive sleep apnea. An absence of ovulation, high levels of androgens, and cyst formation in both ovaries are observed in most of the patients with polycystic ovary syndrome. The disease is also the major cause of anovulatory infertility, causing trouble in women to conceive naturally. Unwanted hair growth, weight gain, dark patches,

Angina Therapeutics Pipeline Analysis - Pharmaceutical Research Report 2018

Angina is a condition in which chest pain occurs when the heart muscle doesn’t get enough oxygen-rich blood. Patients having angina suffer from squeezing and pressure in the chest, and pain in the shoulder, arms, neck, and jaws. Angina is one of the symptoms of cardiovascular disease such as coronary heart disease. In coronary heart disease, plaques build up in the coronary arteries that reduce the flow of oxygen-rich blood

Cerebrovascular Disease Therapeutics Pipeline Review 2018

Cerebrovascular disease also known as stroke, is a condition caused by cerebral ischemia or haemorrhage. Ischemic events are further classified on the basis of occurrences of (in vertebrobasilar or carotid distribution) and duration of symptoms. Facial weakness, vertigo, dysphagia, diplopia, dysarthria, gait ataxia, hemisensory numbness, hemiparesis, limb dysmetria, cortical blindness, and bilateral weakness and numbness are some of the symptoms observed in the patients with ischemic stroke. Cerebrovascular disease can

NF-kB Inhibitors Therapeutics Analysis - Clinical Trials & Results, Designation …

The study analyzed that the NF-kB inhibitors therapeutics pipeline comprises approximately 17 drug candidates in different stages of development. Nuclear factor-kappa B (NF-kB) is the transcription factor which is involved in the regulation of over 500 genes, that are responsible for cell proliferation, survival, invasion, metastasis, angiogenesis and inflammation. Therefore, development of therapeutics that acts as NF-kB inhibitors, can treat various diseases including cancer and chronic inflammation. Explore Report Sample at:

Neurofibromatosis Pipeline Analysis by Therapeutics, Clinical Trials, Patents an …

The study analyzed that the Neurofibromatosis therapeutics pipeline comprises of approximately 25 therapeutic candidates in different stages of development. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/neurofibromatoses-therapeutics-pipeline-analysis/report-sample Majority of the pipeline drug candidates are being developed to be administered by oral route. Celldex Therapeutics Inc. and Merck Co. Inc. are in the process of developing a monoclonal antibody drug candidate, CDX0158, and Pembrolizumab respectively for the treatment of NF. Lixte Biotechnology Holdings Inc. is in

Presbyopia Therapeutics Pipeline Analysis 2018

Presbyopia Pipeline Analysis The study analyzed that the presbyopia therapeutics pipeline comprises nine drug candidates in different stages of development. Presbyopia is an age-related eye condition that causes visual impairment gradually. The disease has been described as "an irreversible optical failure, an unexplained evolutionary blunder that comes as a psychologic shock”. Though not incapacitating if corrected, presbyopia without optical correction results in an inability to perform once-effortless near tasks at a

Acne Vulgaris Therapeutics - Analysis, Patient Size, Epidemiology Forecast to 20 …

Acne vulgaris currently exhibits a growing pipeline with approximately 49 drug candidates. Acne vulgaris epidemiology analysis forecasts an increase in the total number of prevalent cases in population aged between 10 to 45 years in the 7MM, from 166 million cases in 2016 to 178 million cases in 2023. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/acne-vulgaris-therapeutics-pipeline-analysis/report-sample Various drug candidates have shown positive clinical results and are proceeding towards further development. For instance, In May

Meningioma Therapeutics Pipeline Insight 2018 - Clinical Trials, Patent, Collabo …

Meningioma is a type of cancer that affects the membranes surrounding the spinal cord and brain (also known as meninges). Meningioma is categorized into two types including, benign and malignant. Meningioma can be symptomatized by a headache, seizures, weakness in legs and arms, and vision loss. In some cases, carelessness, memory loss, and, unsteadiness, are also observed in some of the patients. Meningioma can also occur due to the mutation

Meningitis Therapeutics Pipeline Review 2018 - P&S Market Research

Meningitis is an inflammatory disease which is caused by infection due to bacteria, viruses, parasites, and fungi. It can also occur due to autoimmune diseases and certain medications. The infections due to bacteria first attack the upper respiratory tract and then passes to the brain through blood. Pneumococcal meningitis is caused by Streptococcus pneumonia and meningococcal meningitis occurs due to Neisseria meningitides infection. Viral meningitis is generally caused by enteroviruses

Merkel Cell Carcinoma Pipeline Analysis by Therapeutics, Clinical Trials & Resul …

Merkel cell carcinoma is a type of skin cancer that develops as painless bumps, due to sun exposure. Bumps can be red-violet coloured or skin coloured and grow rapidly surrounding lymph nodes. The risk factors associated with merkel cell carcinoma are excessive sun exposure, chronic immune suppression, merkel cell polyomavirus, and aging. The main cause of occurrence of merkel cell carcinoma is somatic mutations in DNA. The tumour formed in

Metachromatic Leukodystrophy Pipeline Therapeutics Review 2018

Metachromatic leukodystrophy (MLD) is an inherited disease that causes fat accumulation in cells. The disease affects the nervous system which produces myelin sheath for insulation and protection of nerves. The fatty deposition, called sulfatides in nerve cells causes the destruction of white matter, which is formed by myelin sheath. It further deteriorates the cognitive functioning of nerves such as an ability to walk, loss of sensation (also known as peripheral

Migraine Therapeutics Pipeline - Analysis, Clinical Trials, Patent and Collabora …

Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. People having migraine generally have frequent attacks that cause, anxiety, stress, hormonal level changes, and

Myocardial Ischemia Pipeline Analysis by Therapeutics, Clinical Trials, Patient …

Myocardial ischemia is a cardiovascular disorder that causes angina, shortness of breath and cardiac arrhythmias. Myocardial ischemia is one of the reasons of the sudden cardiac death. Due to obstruction of coronary blood flow, oxygen and glucose flow is interrupted that causes impairment of cellular metabolism. In an electrocardiogram, the ST-segment depression is observed as the clinical sign of myocardial ischemia. Myocardial ischemia can be diagnosed by echocardiogram, electrocardiogram, cardiac

Nasal Polyps Therapeutics Pipeline Review 2018

Nasal polyps are the type of lesions that arises from the mucosa of the nasal cavity. The cause of nasal polyps is still unknown. According to researchers, chronic inflammation in the nose and nasal sinuses are responsible for the occurrence of nasal polyps. Nasal polyps can be symptomatized by the runny nose, postnasal drip, absent sense of smell, facial pain, pain in upper teeth, snoring, persistent stuffiness, and sense of

Neurofibromatoses Type I Pipeline Analysis - Opportunities sales, Revenue, Gross …

Neurofibromatoses type I is a genetic condition characterized by the growth of tumours along the nerves in the brain, skin and other parts of the body, and skin pigmentation. Neurofibromatoses is an autosomal dominant disorder which is caused by the mutation in NF1 gene, a tumour suppressor gene, that encodes protein to stop growing and dividing in an uncontrolled manner. The condition usually begins in early childhood, which causes flat

Nocturia Pipeline Analysis by Therapeutics, Diagnostics, Patient and Drugs Polic …

Nocturia is a condition that is characterized by the need of more than one times micturition per night. The disease is divided into two categories, lower urinary tract dysfunction, and upper urinary tract dysfunction. Nocturia is also considered as a symptom associated with overactive bladder and benign prostate obstruction. Nocturia generally occurs to older people (greater than 65 years of age). Certain risk factors that can cause nocturia in both

Proteasome Inhibitors Pipeline Review 2017 - Clinical Trials, Patents, Designati …

The study analyzed that the proteasome inhibitor therapeutics pipeline comprises approximately 20 drug candidates in different stages of development. Protein degradation and synthesis in the body are regulated by proteasome activity of multimeric protease complex. The protein conjugated to multiple units of polypeptide proteasome ubiquitin are degraded by proteasome. The accumulation of ubiquitinated proteins can lead to apoptosis. The proteasome units include 20S core catalytic complex and 19S regulatory subunits

Retinitis Pigmentosa Therapeutics Pipeline Review 2017 - Clinical Trials & Resul …

Retinitis pigmentosa, also known as retinitis, is a degenerative eye disease that occurs due to the progressive degeneration of the rod photoreceptor cells in the retina of eye. The study analyzed that the retinitis pigmentosa therapeutics pipeline comprises approximately 38 drug candidates in different stages of development. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/retinitis-pigmentosa-therapeutics-pipeline-analysis/report-sample Orphan drug designations from the regulatory bodies such as Food and Drug Administration (FDA), European Medicines Agency (EMA) and Ministry

Hypertrophic Scars Therapeutics Segmental Analysis by Therapeutics, Diagnostics, …

Body cells known as myofibroblasts produce excessive collagen during healing process which can be deposited as a bump and later changes to a hypertrophic scar. The study analyzed that the hypertrophic scars therapeutics pipeline comprises approximately nine drug candidates in different stages of development. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/hypertrophic-scars-therapeutics-pipeline-analysis/report-sample Majority of the pipeline drug candidates are being developed to be administered by the topical route. SCX-001 cream has demonstrated anti-scarring effects in

Urinary Tract Infections Therapeutics Pipeline Analysis 2018

Urinary tract infection (UTI) refer to a common bacterial infection disease, that occurs in either a community or healthcare setting. Clinically, UTIs are categorized as uncomplicated and complicated. Uncomplicated UTIs typically occur in a healthy adult non-pregnant woman and have no structural or neurological urinary tract abnormalities; these infections are differentiated into cystitis and pyelonephritis. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/utis-therapeutics-pipeline/report-sample According to the research findings, a majority of the drug candidates for

Fibromyalgia Therapeutics - Pipeline Analysis 2018

Fibromyalgia therapeutic pipeline is expected to experience a positive trend in the coming years. Prevalence of fibromyalgia is increasing due to very large number of patients suffering from lifestyle disease, psychological stress, trauma, tension, headaches, anxiety and depression. Some of the significant factors driving the pipeline for fibromyalgia include rising prevalence of fibromyalgia and the increasing health awareness among the population, globally. According to the National Fibromyalgia and Chronic Pain

Ankylosing Spondylitis Therapeutics - Pipeline Review, in-Depth Study on Therape …

Ankylosing spondylitis is an idiopathic disease, associated with HLA-B27, IL23R and ERAP1 genes. Usually, fewer people get affected with ankylosing spondylitis irrespective of activation of genes. Blood test, X-ray test, Magnetic Resonance Imaging (MRI) and physical investigations are some of the ways to effectively diagnose the disease. The disease begins with the inflammation in joints in the vertebrae and pelvic bones and spine. The environmental factors are believed to be

Cataract Therapeutics - Pipeline Review 2018, In-Depth Study on Therapeutics Dev …

Cataract is the clouding of eye lens and it can occur in either one or both the eyes. Cataract is generally more common among people over 80 years of age. According to the National Eye Institute, more than half of the Americans suffer from cataract. Eye lens is transparent and light sensitive and is located at the back of the eye. It helps to focus light rays on retina which

Brain Edema Therapeutics - Pipeline Review 2018, Clinical Trials & Results, Coll …

Brain edema, also known as cerebral edema, occurs as a result of an increase in brain fluid content. Brain edema causes swelling of the brain due to excessive fluid collection in the chambers or ventricles of the brain or accumulation of fluid within the brain tissue itself. The causes of cerebral edema include traumatic brain injury, ischemic stroke, haemorrhages, tumors and infections (toxoplasmosis, meningitis, subdural empyema). Cerebral edema may or

Brain Ischemia Therapeutics - Pipeline Review 2018

Brain edema, also known as cerebral edema, occurs as a result of an increase in brain fluid content. Brain edema causes swelling of the brain due to excessive fluid collection in the chambers or ventricles of the brain or accumulation of fluid within the brain tissue itself. The causes of cerebral edema include traumatic brain injury, ischemic stroke, haemorrhages, tumors and infections (toxoplasmosis, meningitis, subdural empyema). Cerebral edema may or

Breast Cancer Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, …

Breast cancer occurs when cells in breast begin to grow uncontrollably. Cancer cells usually form tumor and can be felt as a lump or seen under x-ray. Mostly, breast cancer begins in the duct that carries milk to the nipple, while some breast cancer cells start in the glands that make breast milk. As per National Institutes of Health (NIH), in the U.S., 14.6% of all new cancer cases diagnosed

US Benign Prostatic Hyperplasia (BPH) Procedures - Development, Growth and Forec …

Increase in the aging population in the U.S in the next few years, is expected to create high demand for BPH treatments, since the population aged 50 years and above is more prone to BPH, and therefore tend to opt for various treatments that involve the use of procedures such as TURP, TUIP and laser based treatments. According to the National Institute of Health, it has been estimated that around

Benign Prostatic Hyperplasia Procedures - Global Procedures, Development, Growth …

Benign Prostatic Hyperplasia Procedures is expected to grow at a CAGR of 2.3% during 2017 - 2023. Increasing life expectancy and fall in the birth rates are the major reasons for rise in the aging population. The people in this category require extensive care, since they are more prone to illness due to low immunity levels and longer recovery time. Increase in the aging population in the U.S., Germany, China and

Post-Operative Pain Therapeutics, 2017 - Pipeline Analysis, Clinical Trials, Col …

The study analyzed that the post-operative pain therapeutics pipeline comprises approximately 39 drug candidates in different stages of development. Post-operative pain is one of the most common problem experienced by a person after any surgery. The intensity of pain can vary from acute to chronic depending upon the time it lasts. It starts when pain receptors activate an electrical signal that travels to the spinal cord. The spinal cord then

Friedreich's Ataxia Therapeutics - Pipeline Analysis, Clinical Trials & Results, …

the Friedreich's ataxia therapeutics pipeline comprises approximately 17 drug candidates in different stages of development. Friedreich’s ataxia is an autosomal recessive inherited genetic disorder that progressively damages the nervous system. Its initial symptoms include ataxia, impaired muscle coordination and impaired speech. This results in development of dysarthria, scoliosis, heart diseases and diabetes, but does not affect cognitive function. According to the research findings, most of the drug candidates in Friedreich's ataxia

Technological Advancements to Lead the Process of Drug Development for the Treat …

The study analysed that the diabetic foot ulcer pipeline comprises of approximately 27 drug candidates in different stages of development. Explore Report at: www.psmarketresearch.com/market-analysis/diabetic-foot-ulcers-therapeutics-pipeline-analysis Diabetic foot ulcer is a serious complication of diabetes and can be defined as the ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients. Diabetic foot ulcer is categorized into two types namely; neuropathic foot where neuropathy dominates and neuroischemic

Ewing sarcoma has a Promising Pipeline with approximately 29 Drug Candidates

Ewing sarcoma pipeline comprises approximately 29 drug candidates in different stages of development. Ewing sarcoma is a condition in which formation of cancer or tumor takes place in bones and soft tissues. The symptoms associated with Ewing sarcoma include pain as well as swelling in the chest, back, legs, pelvis and arms, lumps in arms, bone fracture, weight loss, loss of appetite, fatigue, malaise, etc. Explore Report Description at: www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis Major companies

CDK Inhibitors Therapeutics Pipeline Analysis 2017

The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development. CDKs are the catalytic subunits of serine or threonine protein kinases that regulate the checkpoints in the cell cycle to control the proliferative capacity of cancerous cells. These proteins form cyclin-CDK complex which gets activated after phosphorylation, leading to cell proliferation. Explore Report at: www.psmarketresearch.com/market-analysis/cdk-inhibitors-therapeutics-pipeline-analysis USFDA granted Breakthrough Therapy Designation to a drug

Spinal Muscular Atrophy Therapeutics Exhibit Promising Pipeline with approximate …

The study analyzed that the therapeutics pipeline comprises approximately 16 drug candidates in different stages of development. Spinal muscular atrophy is defined as the inherited genetic disease that is characterized by a failure of nerve cells called motor neurons. Motor neurons are responsible to accept the nerve impulses transmitted from the brain to the spinal cord and transmit the impulses to the muscle with the help of peripheral nerves. The

PTSD Exhibits Emerging Pipeline with 23 Drug Candidates

The study analysed that the PTSD pipeline comprises of 23 drug candidates, of which one drug candidate is in the Phase III stage of development, two drug candidates are in the Phase II stage of development, seven drug candidates are in the Pre-Clinical stage of development, two drug candidates are in Discovery stage, one drug candidate is in Unknown Clinical stage, one drug candidate is in the Discontinued stage and

Malignant Mesothelioma Therapeutics Pipeline Analysis, 2017 By P&S Market Resear …

Malignant mesothelioma is a rare type of cancer that is characterised by tumor formation in the mesothelium, a tissue layer that covers the pleural organs such as heart, abdomen, lungs and other organs. The biggest risk factor of the disease is exposure to asbestos, a silicate mineral. Some of the major symptoms of the disease include cough, shortness of breath and pain in the chest. The symptoms in malignant mesothelioma

Critical Limb Ischemia (CLI) Therapeutics Pipeline Analysis, 2017 - Clinical Tri …

Critical limb ischemia (CLI) is a severe peripheral arterial disease (PAD) characterised by blockage in the arteries of the lower limbs, which in turn reduces blood-flow. The primary cause of the disease is atherosclerosis or the buildup of fatty deposits called plaque in the arteries. Other risk factors for the disease include hypercholesterolemia, obesity, smoking, hypertension and diabetes. Diabetes is a significant risk factor because it is often linked with

Niemann–Pick Disease Therapeutics Pipeline Analysis, 2017 by P&S Market Resear …

Niemann-Pick Disease is a type of lipid storage disorder characterised by accumulation of fatty substances in organs such as spleen, liver, and brain, eventually causing cell death resulting in malfunctioning of major organ systems. Its pathogenesis involves deficiency of a lysosomal enzyme called acid sphingomyelinase, and is mainly caused by genetic mutation. Niemann-Pick disease is majorly prevalent in North America, South America, Europe, Africa, Asia, and Australia. There are three

Hypercholesterolemia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Re …

Hypercholesterolemia is a disorder characterised by abnormally increased levels of cholesterol in the blood. The high levels of cholesterol increase a person's risk of developing cardiovascular diseases such as coronary artery disease, which involve build-up of plaque in the coronary arteries, in turn putting a person across the risk of suffering a heart attack. The main causes of hypercholesterolemia include heredity, diet high in saturated fats and cholesterol, other diseases

Go To Page: 1 3